High-Potency Cannabis Linked to Increased Psychosis and Addiction Risk

High-Potency Cannabis Linked to Increased Psychosis and Addiction Risk

es.euronews.com

High-Potency Cannabis Linked to Increased Psychosis and Addiction Risk

A large-scale study shows high-potency cannabis derivatives (THC>5mg or 10%) significantly increase psychosis, schizophrenia, and addiction risks within 12 hours of use, affecting an estimated 4.3 million daily/near-daily users in the EU despite cannabis's illegality there.

Spanish
United States
HealthSciencePublic HealthMental HealthAddictionCannabisSchizophreniaThcPsychosisEuropean Medicines Agency
European Medicines Agency (Ema)Annals Of Internal MedicineColorado School Of Public Health
Jonathan Samet
What are the conflicting findings regarding the effects of high-THC cannabis on anxiety and depression, and what factors might explain these discrepancies?
The study, encompassing data from 99 studies and over 220,000 individuals, confirms previous research linking high-THC cannabis to mental health issues. While some studies suggest potential benefits for anxiety and depression in specific populations (e.g., those with cancer), the overall risk of psychosis and addiction outweighs any potential advantages.
What are the immediate health risks associated with high-potency cannabis derivatives, and how significant are these risks given current consumption rates?
A new study reveals that high-potency cannabis derivatives, with THC concentrations exceeding 5mg or 10% per serving, significantly increase the risk of psychosis and schizophrenia, particularly within 12 hours of consumption. These potent products, including concentrates like hash oil, also heighten the risk of cannabis addiction.
What policy implications arise from this study's findings regarding the regulation and public health messaging surrounding high-potency cannabis products in the EU, considering the estimated 4.3 million daily/near-daily users?
This research emphasizes the urgent need for stricter regulations on high-potency cannabis products. The significant increase in THC concentration (23% in 2023 resin vs. 11% in the plant) necessitates public health interventions to mitigate the rising risk of severe mental health consequences among users. Long-term, frequent use is linked to respiratory problems and worsening psychotic symptoms by the European Medicines Agency (EMA).

Cognitive Concepts

4/5

Framing Bias

The article's headline (not provided, but inferred from the text) and introduction likely emphasize the dangers of high-THC cannabis, setting a negative tone from the start. The repeated mention of negative health consequences, particularly psychosis and addiction, before discussing any potential benefits, frames the issue in a predominantly negative light. The use of terms like "powerful derivatives" and "alarming" further strengthens this negative framing.

3/5

Language Bias

The article uses language that leans toward a negative portrayal of high-THC cannabis. Terms such as "powerful derivatives," "alarming," and consistently highlighting the risks (e.g., 'fomentar la adicción') contribute to this negative framing. While the article cites a scientific study, the choice of words used to describe the findings amplifies the negative aspects. More neutral phrasing could include 'associated with' or 'linked to' instead of stronger, more negative terms like "fomenta" (foments).

3/5

Bias by Omission

The article focuses heavily on the negative effects of high-THC cannabis, mentioning some studies suggesting benefits for anxiety and depression in specific populations (those with cancer or other neurological disorders). However, it doesn't delve deeply into these studies or offer a balanced view of the potential therapeutic uses of cannabis, potentially leading to an incomplete picture for the reader. The article also omits discussion of potential harm reduction strategies for cannabis users.

3/5

False Dichotomy

The article presents a somewhat false dichotomy by primarily focusing on the negative health effects of high-THC cannabis without sufficiently exploring the complexities of cannabis use, including potential therapeutic benefits and the varying effects based on individual factors like pre-existing conditions, frequency of use, and the specific cannabis product consumed. It frames the issue as high-THC versus negative health outcomes, neglecting a broader spectrum of potential impacts.

Sustainable Development Goals

Good Health and Well-being Negative
Direct Relevance

The study highlights the negative impact of high-concentration THC cannabis derivatives on neurological health, increasing the risk of psychosis and schizophrenia, and fostering addiction. This directly contradicts the SDG target of ensuring healthy lives and promoting well-being for all at all ages.